|
San Diego, CA - December 16, 2003
LA JOLLA PHARMACEUTICAL
SUBMITS NEW DRUG APPLICATION FOR RIQUENT™
San Diego, CA - December 2, 2003
LA JOLLA PHARMACEUTICAL DISCOVERS
SMALL MOLECULE THAT PRODUCES POSITIVE RESULTS IN AUTOIMMUNE DISEASE
AND INFLAMMATION MODELS
San Diego, CA - November 17, 2003
LA
JOLLA PHARMACEUTICAL COMPANY PRESENTS RESULTS LINKING ANTIBODIES
TO dsDNA WITH RENAL FLARES
San Diego, CA - November 14, 2003
LA JOLLA PHARMACEUTICAL COMPANY
ADDED
TO NASDAQ BIOTECHNOLOGY INDEX
San Diego, CA - November 6, 2003
LA JOLLA PHARMACEUTICAL COMPANY
REPORTS THIRD QUARTER 2003 FINANCIAL RESULTS
San Diego, CA - October 27, 2003
LA JOLLA PHARMACEUTICAL COMPANY
PRESENTS FIVE POSTERS AT AMERICAN COLLEGE OF RHEUMATOLOGY
San Diego, CA - September 22, 2003
LA JOLLA PHARMACEUTICAL COMPANY
TO PRESENT AT
UBS WARBURG LIFE SCIENCES CONFERENCE
San Diego, CA - August 13, 2003
LA JOLLA PHARMACEUTICAL COMPANY
COMPLETES STOCK OFFERING
San Diego, CA - August 4, 2003
LA
JOLLA PHARMACEUTICAL COMPANY
REPORTS SECOND QUARTER 2003 FINANCIAL
RESULTS
San Diego, CA - July 24, 2003
LA JOLLA PHARMACEUTICAL
PROVIDES UPDATE ON NDA FILING REGARDING ACCELERATED APPROVAL
San Diego, CA - June 19, 2003
RIQUENT™ PHASE 3
DATA REVIEWED AT EULAR RHEUMATOLOGY CONFERENCE
San Diego, CA - June 16, 2003
LA JOLLA PHARMACEUTICAL ANNOUNCES
HEALTH-RELATED QUALITY OF LIFE RESULTS FROM RIQUENT™ PHASE
3 TRIAL
San Diego, CA - June 3, 2003
LA JOLLA PHARMACEUTICAL COMPANY TO PRESENT AT NEEDHAM BIOTECHNOLOGY
CONFERENCE
San Diego, CA - May 12, 2003
LA JOLLA PHARMACEUTICAL COMPANY
REPORTS FIRST QUARTER 2003 FINANCIAL RESULTS
San Diego, CA - May 5, 2003
LA
JOLLA PHARMACEUTICAL PLANS TO SUBMIT
NDA FOR RIQUENT™
San Diego, CA - April 10, 2003
LA
JOLLA PHARMACEUTICAL ANNOUNCES CLOSURE
OF
OPEN-LABEL SAFETY STUDY OF RIQUENT™
San Diego, CA - March 31, 2003
RESULTS
FROM TWO RIQUENT™ TRIALS SHOW LUPUS
PATIENTS WITH SUSTAINED REDUCTIONS IN
ANTIBODIES TO dsDNA HAVE FEWER RENAL
FLARES
San Diego, CA - March 13, 2003
LA
JOLLA PHARMACEUTICAL COMPANY TO PRESENT
AT
SG COWEN HEALTHCARE CONFERENCE
San Diego, CA - March 4, 2003
LA
JOLLA PHARMACEUTICAL COMPANY REPORTS
FOURTH QUARTER 2002 FINANCIAL RESULTS
San Diego, CA - March 3, 2003
LA
JOLLA PHARMACEUTICAL TO PRESENT AT LEHMAN
BROTHERS CONFERENCE
San Diego, CA - February 24, 2003
LA
JOLLA PHARMACEUTICAL TO PRESENT AT BIO
CEO & INVESTOR CONFERENCE
San Diego, CA - February 18, 2003
LA
JOLLA PHARMACEUTICAL ANNOUNCES CONFERENCE
CALL TO DISCUSS PHASE III RESULTS OF
RIQUENT™ FOR LUPUS RENAL DISEASE
San Diego, CA - February 18, 2003
LA
JOLLA PHARMACEUTICAL ANNOUNCES RESULTS
OF
PHASE III TRIAL OF RIQUENT™
San Diego, CA - January 30, 2003
LA
JOLLA PHARMACEUTICAL TO PRESENT AT MERRILL
LYNCH CONFERENCE
|